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Abstract
The human Discs Large 1 (DLG1) protein uses two of its three PDZ domains to interact with the C-terminal peptide of the
Adenomatous Polyposis Coli (APC) tumor suppressor protein. The DLG1/APC complex inhibits the cell cycle progression
from the G0/G1 to the S phase, regulates epithelial cell migration and morphogenesis, and is required for polarization of the
microtubule cytoskeleton. However, the molecular details of how DLG1 recognizes APC is not clear. In this study, we
performed biochemical and biophysical assays to investigate the interactions between PDZ domains of DLG1 and the C-
terminal peptide of APC. In addition, we determined the crystal structures of the PDZ1 and PDZ2 domains of DLG1 each in
complex with the C-terminal 11-residue peptide of APC. Our biochemical, biophysical, and structural results revealed
structural elements and residues on PDZ1 and PDZ2 domains of DLG1 and on APC crucial for their mutual interaction. In
particular, our results show that the b2/b3 loops of PDZ1 and PDZ2 play important roles in contributing to the binding
affinities between PDZ domains and APC, through interacting with the residues upstream of the canonical PDZ-binding S/T-
X-V motif. The results provide new insights into the binding mode of a defined C-terminal segment of APC by the PDZ
domains of DLG1.
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Introduction
The human Discs Large 1/Synapse Associated Protein 97 (here
referred to as DLG1) protein is a member of the membrane-
associated guanylate kinase (MAGUK) family, a protein family that
has been identified at sites of cell-cell contacts in different organisms
including humans [1]. The proteins of the MAGUK family,
including DLG1, PSD-95/SAP 90, PSD-93/chapsyn 110, SAP
102, ZO-1, and ZO-2 [2], are multidomain proteins consisting of
three PSD-95/Discs Large/ZO1 (PDZ) domains, an Src Homology
3 (SH3) domain, a HOOK region, and a guanylate kinase-like
(GUK) domain (Figure 1A). The GUK domains in MAGUK
proteins lack key residues required for ATP binding, and it is
assumed that guanylate kinase-related regions of these multidomain
proteins have adopted a role in protein-protein interactions rather
than having an enzymatic function [1]. PDZ domains are made up
of ,90 amino acids and contain a conserved GLGF tetrapeptide
motif. They mediate protein-protein interactions by binding to the
extreme carboxy terminal S/T-X-V motif of target proteins.
The human tumor suppressor Adenomatous Polyposis Coli
(APC) is a 2,843-residue protein. It contains an N-terminal
oligomerization domain, an armadillo repeat domain, a central
region containing multiple b-catenin-binding and Axin-binding
repeats, and a PDZ-binding motif (Thr2841-Ser2842-Val2843) at
its extreme C-terminus [3]. The second PDZ domain of DLG1
(residues 315–410, referred to as PDZ2 hereafter) has been
reported to bind to APC [4], while neither the first PDZ domain
(residues 220–310, PDZ1) nor the third PDZ domain (residues
462–550, PDZ3) of DLG1 has been reported to show substantial
APC-binding activity [4]. The APC/DLG1 complex was reported
to negatively regulate cell cycle progression from the G0/G1 to the
S phase, and over-expression of mutant DLG1 interfered with the
cell cycle blocking activity of APC [5]. In addition, it has been
shown that APC links microtubules to plasma membranes through
interaction with DLG1, so that epithelial cell migration and
morphogenesis can be properly regulated [6]. Furthermore, the
spatially-localized interaction between APC and DLG1 has been
shown to be activated by Cdc42 and the Par6-PKCf complex at
the leading edge of migrating cells, and the interaction between
APC and DLG1 is required for polarization of the microtubule
cytoskeleton [7].
In addition to APC, several viral proteins implicated in
tumorigenesis have also been reported to interact with the PDZ
domains of DLG1. For example, the high risk human papilloma-
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23507virus (HPV) E6 oncoproteins [8,9], the adenovirus 9 E4 ORF1
protein [8], and human T cell leukemia virus (HTLV) type I Tax
protein [10] all contain the S/T-X-V motif, and bind to the PDZ2
domain of DLG1. By binding to the PDZ2 domain of DLG1,
these viral oncoproteins might subvert the normal physiological
functions of DLG1 during the oncogenic transformation process.
In this study, we investigated the molecular basis of the
interaction between DLG1 and APC through a combination of
biochemical, biophysical, and structural approaches. We per-
formed the glutathione sulfur transferase (GST) pull-down assay as
well as the isothermal titration calorimetry (ITC) assay to analyze
the binding between wild-type (WT) or mutant PDZ domains of
DLG1 and various C-terminal peptides of APC. In addition, we
determined the crystal structure of the PDZ1 domain in complex
with the C-terminal 11 residues of APC (APC-C11) as well as the
crystal structure of the PDZ2 domain in complex with APC-C11.
Both our binding and structural results show that PDZ1 also
interacts with APC, though the interaction is weaker than that
Figure 1. The interaction between the PDZ domains of DLG1 and APC. (A) The domain structure of DLG1. The three PDZ domains, the SH3
domain, the HOOK region, and the GUK domain of DLG1 are shown, with their boundary residue numbers indicated. (B) Structure-based sequence
alignment and secondary structures of the PDZ1, PDZ2, and PDZ3 domains of DLG1. The protein sequences of three PDZ domains were aligned by
the ClustalW method. Identical residues in all three PDZ domains are highlighted in yellow, and identical residues in any two PDZ domains are shown
in gray. Residue numbers of PDZ1 are shown, and residue numbers of PDZ2 are indicated in parentheses. Residues of PDZ1 and PDZ2 that bind to
APC using van der Waals interactions, hydrogen bonding with main chains, and hydrogen bonding with side chains are designated by red circles,
blue squares, and green triangles, respectively. (C) GST pull-down assay for the interaction between APC-C11 and various PDZ domains of DLG1. Blue
arrow indicates the band of GST-APC-C11, and red arrowheads designate the bands of DLG1 PDZ domains. (D) GST pull-down assay for the
interaction between APC-C4 and various PDZ domains of DLG1. GST pull-down assay between GST-APC-C11 and PDZ1-PDZ2 was also performed in
parallel as a comparison. Blue arrow indicates the band of GST-APC-C4 or GST-APC-C11, and red arrowheads designate the bands of DLG1 PDZ
domains.
doi:10.1371/journal.pone.0023507.g001
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region, we find that the b2/b3 loops of PDZ1 and PDZ2
contribute to the binding affinity for APC, through interacting
with APC residues upstream of the canonical S/T-X-V motif. Our
results thus provide new insights into the formation of the DLG1/
APC complex and its function.
Results
In vitro binding of the C-terminal peptide of APC to the
PDZ domains of DLG1
To complement and extend the earlier analysis of the
interaction between APC and DLG1, we created two different
GST-tagged APC C-terminal peptides: the C-terminal 11 residues
of APC (GST-APC-C11: RHSGSYLVTSV), and the C-terminal
4 residues of APC (GST-APC-C4: VTSV). Purified PDZ1, PDZ2,
and PDZ3 proteins, which have high pairwise sequence similarities
(Figure 1B), as well as the tandem PDZ1-PDZ2 protein construct
(residues 220–410), were used to investigate their interaction with
GST-tagged APC C-terminal peptides. Both our GST pull-down
assay and ITC assay results showed that GST-APC-C11 bound
most strongly to the PDZ2 domain (the dissociation constant
Kd=1.05 mM, Figure 1C, Figure 2B, and Table 1) and to PDZ1-
PDZ2 (Figure 1C). Moreover, GST-APC-C11 showed somewhat
weaker, but detectable binding to the PDZ1 domain
(Kd=18.2 mM, Figure 1C, Figure 2A, and Table 1). On the other
hand, the binding to APC-C11 was barely detectable for the PDZ3
domain (Figure 1C, Figure 2C, and Table 1), which is consistent
with previous findings [4]. Interestingly, the interactions between
GST-APC-C4 and PDZ1, PDZ2, and PDZ1-PDZ2 were
significantly weaker compared to GST-APC-C11, with no
detectable heat of reaction (Figure 1D, Figure 2D, Figure 2E,
and Table 1). Therefore no Kd value could be fit. These results
indicate that the canonical S/T-X-V PDZ-binding motif at the C
terminus of APC is necessary but not sufficient for efficient binding
with PDZ domains. The amino acids upstream of this motif may
modulate the binding specificity and affinity. Similar results have
also been found for the interaction of NMDA receptor subunits
with DLG1, PSD-95, and SAP 102 [11,12].
The b2/b3 loops of PDZ1 and PDZ2 play important roles
in the interaction with APC
The 3D structures of the three PDZ domains of DLG1 have
been determined in the free forms [13–15]. They share very
similar structures, and the ligand binding pockets are also
conserved. Comparison of their amino acid sequences revealed
that PDZ1 and PDZ2 have six additional residues in the b2/b3
loops compared to PDZ3 (Figure 1B). It has been reported that
deletion of six residues from the b2/b3 loops of the PDZ1 and
PDZ2 domains of PSD-95 decreases the binding affinity for the
Kv1.4 potassium channel and the NMDA receptor NR2B subunit
significantly [16]. The residues in the b2/b3 loops of PDZ
domains in other proteins have also been implicated in determi-
ning their target ligand binding affinities [17,18]. In order to know
whether the b2/b3 loop also plays an important role in the
interaction between APC and DLG1, we created a similar mutant
of PDZ2 deleting residues 339–346. Our results showed that
deletion of these eight residues from PDZ2 significantly decreases
the interaction between PDZ2 and APC-C11, with no detectable
heat of reaction (Figure 3A, Figure 3C, and Table 1). The
importance of the b2/b3 loop is also supported by the fact that the
PDZ3 domain, which possesses high overall sequence homology
with PDZ1 and PDZ2 but lacks this loop (Figure 1B), displayed no
binding affinity for APC-C11 (Figure 1C, Figure 2C, and Table 1).
Our GST pull-down assay result indicates that the interaction
between PDZ2 and APC-C11 is stronger than that between PDZ1
and APC-C11 (Figure 1C, Figure 2A, Figure 2B, and Table 1). A
comparison of the amino acid sequence of the b2/b3 loops of PDZ1
and PDZ2 shows that Gln340 in PDZ2 is changed to Pro245 in
PDZ1 (Figure 1B). This residue difference might account for the
higher affinity between PDZ2 and APC. Indeed, mutation of
Q340P leads to substantially weaker interaction between PDZ2 and
APC-C11 (Figure 3B). The dissociation constant Kd value increases
from 1.05 mM for the WT PDZ2/APC-C11 complex to 9.80 mM
for the PDZ2 Q340P mutant/APC-C11 complex (Figure 2B,
Figure3D,andTable1).Similarresultshave alsobeenfoundforthe
interaction between the NR2B subunit of NMDA receptors and
DLG1, in which the P245Q mutation in PDZ1 led to a 2-fold
increase in the binding affinity for NR2B [13].
Crystal structures of the PDZ1/APC-C11 complex and the
PDZ2/APC-C11 complex
In order to obtain detailed structural information on the
DLG1/APC interaction, we set up crystallization screens for
purified PDZ1/APC-C11, PDZ2/APC-C11 and PDZ1-PDZ2/
APC-C11 protein complexes. Unfortunately, attempts to crystal-
lize the PDZ1-PDZ2/APC-C11 complex were unsuccessful, while
crystals were successfully obtained for the PDZ1/APC-C11
complex and the PDZ2/APC-C11 complex. The corresponding
crystal structures were determined using the method of molecular
replacement, to resolutions of 2.30 A ˚ and 2.20 A ˚, respectively.
After refinement, the R-factor/Rfree was 17.2%/23.2% for the
PDZ1/APC-C11 complex, and 20.4%/24.7% for the PDZ2/
APC-C11 complex (Table 2).
In the crystal structure of the PDZ1/APC-C11 complex, six
complexes can be found in each asymmetric unit. Only one complex
was found with electron density for seven residues of APC (residues
2837–2843, SYLVTSV), and the others contain fewer residues of
APC. The most complete complex was chosen to analyze the
interaction between PDZ1 and APC. In the crystal structure of the
PDZ2/APC-C11 complex, four PDZ2 monomers and one PDZ2/
APC-C11 heterodimer can be found in each asymmetry unit.
Despite considerableeffort,onlyone APCpeptide molecule(residues
2838–2843) could be located in complex with PDZ2 (Figure S1).
TherewasnointerpretableelectrondensityfortheAPCpeptidenear
the other four PDZ2molecules inthe asymmetric unit. Compared to
the PDZ1/APC complex, the interaction between PDZ2 and APC
seems to be weaker because of the low occupancy of APC molecules.
This finding is in contrast to our GST pull-down and ITC assay
results (Figure 1C, Figure 2A, Figure 2B, and Table 1). We speculate
that it is due to the low affinity between PDZ2 and APC-C11 under
our crystallization condition. When we performed the GST pull-
down assay using a buffer similar to the condition in which PDZ2/
APC-C11 crystallized, the interaction between PDZ2 and APC-C11
was also found to be weaker than that between PDZ1 and APC-C11
(data not shown), which was consistent with this speculation.
The interaction interface between the PDZ1/PDZ2
domains and the APC C-terminal peptide
The crystal structures of PDZ1 and PDZ2 are very similar to
structures of other typical PDZ domains, each with five b strands
and two a helices (Figure 4). As in other structures of PDZ-ligand
complexes, Val2843 and Thr2841 of the APC C-terminal peptide
are critical for the binding, through interaction with residues on
the b2 strand, the a2 helix, and the b1/b2 loop of PDZ1/PDZ2.
The most C-terminal residue, APC-Val2843, plays the most
important role in mediating the interaction with PDZ1/PDZ2. Its
Structure of the DLG1/APC Complex
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chain amide proton of PDZ1-Leu234/PDZ2-Leu329 and PDZ1-
Gly235/PDZ2-Gly330 from the b1/b2 loop, and PDZ1-Phe236/
PDZ2-Phe331 from the start of the b2 strand. In addition, the
Val2843 side chain is accommodated in a hydrophobic pocket
formed by the apolar side chains of PDZ1-Leu234/PDZ2-Leu329
from the b1/b2 loop, PDZ1-Phe236/PDZ2-Phe331 and PDZ1-
Ile238/PDZ2-Ile333 from the b2 strand, and PDZ1-Val293/
PDZ2-Val388 and PDZ1-Leu296/PDZ2-Leu391 from the a2
helix (Figure 1B, Figure 5A, and Figure 5B). When APC-Val2843
Figure 2. Using the ITC assay to analyze the interactions between various PDZ domains and APC-C11/APC-C4. (A) The PDZ1 protein
was titrated into the GST-tagged APC-C11 protein, and the dissociation constant (Kd) of the PDZ1/APC-C11 complex was measured to be 18.2 mM. (B)
The PDZ2 protein was titrated into the GST-APC-C11 protein, and the dissociation constant (Kd) of the PDZ2/APC-C11 complex was measured to be
1.05 mM. (C) The PDZ3 protein was titrated into the GST-APC-C11 protein, and no detectable interaction was observed. (D) The PDZ1 protein was
titrated into the GST-APC-C4 protein, and no detectable interaction was observed. (E) The PDZ2 protein was titrated into the GST-APC-C4 protein,
and no detectable interaction was observed.
doi:10.1371/journal.pone.0023507.g002
Structure of the DLG1/APC Complex
PLoS ONE | www.plosone.org 4 August 2011 | Volume 6 | Issue 8 | e23507was truncated from the C-terminus of the APC-C11 peptide, no
interaction could be observed between the resulting APC peptide
and PDZ1/PDZ2 (Figure S2).
APC-Thr2841 is the second most crucial residue for the binding
between APC and PDZ1/PDZ2. Its side chain forms an essential
hydrogen bond with the imidazole group of PDZ1-His289/PDZ2-
His384 from the start of the a2 helix. Moreover, its main chain
NH and CO groups form a pair of hydrogen bonds with the
backbone of PDZ1-Ile238/PDZ2-Ile333 from the b2 strand.
Furthermore, the aliphatic part of its side chain makes van der
Waals interaction with PDZ1-Val293/PDZ2-Val388 from the a2
helix (Figure 1B, Figure 5A, and Figure 5B).
Interestingly, in addition to these canonical associations, there
are more interactions observed between PDZ1 and APC-C11 in
our crystal structure. The N-terminus of the APC-C11 peptide
extends towards the groove between the b2/b3 loop and the b2
strand. The b2/b3 loop seems to facilitate the binding of APC by
forming interactions with residues upstream of the canonical S/T-
X-V PDZ-binding motif. For example, APC-Val2840 forms van
der Waals contacts with Ala239 and the aliphatic part of the side
chain of Ser237. In addition, the carbonyl oxygen of Leu2839
forms a hydrogen bond with the side chain of Asn244 at the b2/b3
loop, which is conserved in PDZ2. Furthermore, the aliphatic
portions of the side chains of APC-Tyr2838 and APC-Ser2837
make van der Waals interactions with Pro245 and Ala239,
respectively (Figure 5A). These interactions are observed in most
of the six PDZ1 domains in complex with APC-C11 in the
asymmetric unit. Notably, the conformations of the b2/b3 loops
are also invariable for the different PDZ1 domains (Figure S3).
When the last twenty residues of human, Xenopus,z e b r a f i s h ,
sea urchin APC, and C. elegans APR-1 are aligned, it is found
that the two residues of the canonical S/T-X-V motif, Thr2841
and Val2843, are conserved among all APC homologues. In
addition, Ser2835, Gly2836, Ser2837, Tyr2838, Leu2839, as
well as Val2840 are conserved among at least three out of the
five homologues of APC used for alignment (Figure 5C). The
conservation of these residues down to zebrafish and sea urchin
underscores the importance of these residues, which are
involved in the interaction with the b2/b3l o o p so fD L G 1
PDZ domains (Figure 5A). In contrast, most of the human APC
residues before Ser2835 are not as conserved (Figure 5C). The
conservation of the DLG1-binding residues in APC suggests that
the formation of the DLG1/APC complex might be present
among all deuterostomes.
Although we did not observe these non-canonical interactions in
the PDZ2/APC-C11 complex structure, it is possible that the
crystallization condition we used for producing crystals of the
PDZ2/APC-C11 complex was not favorable for these interactions.
Most of the residues in PDZ1 mediating non-canonical binding
with APC-C11, including Ser237, Ala239, and Asn244, are
conserved in PDZ2 (Figure 1B). Therefore, it is reasonable to
surmise that these non-canonical associations might also exist
between PDZ2 and APC-C11.
Conformational differences between the free and
APC-bound PDZ1 and PDZ2
When the structures of free and APC-bound forms of PDZ1 are
compared, the conformation of the b2/b3 loop was found to
change upon APC binding. The loop moves outward from the
core of PDZ1 domain, to create a larger groove between it and the
b2 strand (Figure 6A). This movement may facilitate the APC-C11
peptide binding. Although similar movement of the b2/b3 loop
was not observed in our PDZ2/APC-C11 complex structure, we
suspect that it is because the crystallization condition we used was
not favorable for this conformational change, as we discussed
earlier. In the structure of the PDZ2/APC-C11 complex, the b1/
b2 loop moves slightly away from the a2 helix (Figure 6B), whereas
this movement of the b1/b2 loop is not observed in the PDZ1/
APC-C11 complex. This movement may be a result of crystal
packing, since similar movement can also be found in the free
PDZ2 molecules in the same asymmetry unit (Figure S4).
Discussion
It has been reported that in the free form, the PDZ1 and PDZ2
domains of PSD-95 associate with each other to form a tight
interaction [19]. Since the PDZ domains of PSD-95 and DLG1
share very high sequence similarity, analogous interaction between
PDZ1 and PDZ2 might also be present in DLG1. Limited
proteolysis cleaved the three PDZ domains of DLG1 into two
modules. The larger one contained the PDZ1 and PDZ2 domains,
suggesting that PDZ1 and PDZ2 interact with each other and
together form a protease-resistant module [20]. The solution
structure and the crystal structure of PDZ1-PDZ2 of PSD-95 have
been solved previously [19], and the solution structure of PDZ1-
PDZ2 of PSD-95 in complex with cypin, another protein with the
canonical S/T-X-V PDZ-binding motif, has also been determined
recently [21]. It has been suggested that cypin-binding induces
relative movement between PDZ1 and PDZ2 domains of PSD-95
[21]. Using the structural information of PDZ1-PDZ2 of PSD-95,
we can speculate a model of APC-induced inter-domain
conformational change of DLG1. In the free form, the b2/b3
loops of PDZ1 and PDZ2 contact each other (Figure S5A). Upon
APC binding, the APC-C11 peptides are able to enter the grooves
between the b2/b3 loops and the b2 strands of PDZ1 and PDZ2
(Figure S5B). In this situation, the two APC-C11 peptides on both
sides push the b2/b3 loops of PDZ1 and PDZ2 towards the
middle so that the two b2/b3 loops might collide with each other.
Therefore, there has to be a relative movement between PDZ1
and PDZ2 to make a larger space between them and to avoid the
collision of the two b2/b3 loops, thus facilitating the binding of
APC. In this situation, the inter-domain arrangement of PDZ1-
PDZ2 becomes flexible upon APC-binding, which might be the
reason that we were not able to obtain crystals of the PDZ1-
PDZ2/APC-C11 protein complex.
Table 1. Dissociation constants (Kd) of the interaction
between DLG1 PDZ domains and APC-C11/APC-C4 peptides.
DLG APC
DLG/
APC ratio
Kd
(mM)
DH
(kcal/mol)
TDS
(kcal/mol)
PDZ1 APC-C11 0.91860.127 18.267.6 24.0260.82 2.44
PDZ2 APC-C11 0.91660.018 1.0560.22 27.0960.19 1.07
PDZ3 APC-C11 n/a n/a n/a n/a
PDZ1 APC-C4 n/a n/a n/a n/a
PDZ2 APC-C4 n/a n/a n/a n/a
PDZ2
D339–346
APC-C11 n/a n/a n/a n/a
PDZ2
Q340P
APC-C11 1.0460.03 9.8061.11 26.7660.27 0.0793
ITC experiments were performed at 25uC. Typically, a 400 mM PDZ domain of
DLG1 was injected into a 40 mM GST-tagged APC-C11 or APC-C4 protein
solution. ‘‘n/a’’ refers to that no detectable interaction was observed. A negative
value for DH indicates an exothermic reaction while a positive value for DH
indicates an endothermic reaction.
doi:10.1371/journal.pone.0023507.t001
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PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23507Figure 3. The b2/b3 loop of PDZ2 is important for the interaction of PDZ2 with APC-C11. (A–B) Using the GST pull-down assay to analyze
the interactions between the mutant PDZ2 domains and APC-C11. (A) Deletion of residues 339–346 in PDZ2 dramatically decreased the interaction
between PDZ2 and APC-C11. GST-APC-C11 was used for the GST pull-down assay with wild-type (WT) PDZ2 and the mutant of PDZ2 deleting
residues 339–346 (D339–346). (B) Point mutation of Q340P greatly diminished the association between PDZ2 and APC-C11. GST-APC-C11 was used
for the GST pull-down assay with WT and Q340P mutant of PDZ2. Blue arrow indicates the band of GST-APC-C11, and red arrowheads designate the
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loop of PDZ2 and APC-C11 in our structure, our GST pull-down
and ITC assay results support that this interaction is critical for
PDZ2/APC binding (Figure 3A, Figure 3C, and Table 1). Gln340
in the b2/b3 loop of PDZ2 is crucial for high affinity binding with
APC (Figure 3B, Figure 3D, and Table 1), and the P245Q
mutation in PDZ1 leads to a 2-fold increase in binding affinity for
NR2B [13]. We do not know how Gln340 interacts with APC yet,
and alternative crystal forms of PDZ2/APC-C11 are needed to
decipher the structural mechanism of how the b2/b3 loop of
PDZ2 recognizes APC.
There are two tandem PDZ domains (i.e., PDZ1 and PDZ2) in
DLG1, each of which is capable of binding the C-terminal tail of
APC. The presence of two APC-binding sites could enhance the
binding affinity of DLG1 for APC. Moreover, it is possible that
each DLG1 molecule could interact with two APC molecules
inside the cell. Interestingly, another APC-interacting protein, end
binding protein 1 (EB1), is a homodimer and might also bind two
APC [22–24]. In addition, APC is reported to be a dimer medi-
ated by the oligomerization domain at its N-terminus [25].
Therefore, it is reasonable to speculate that inside the cell, one
APC dimer associates with one EB1 dimer and one DLG1 mole-
cule. Through mediation by EB1, the APC dimer is transported
along microtubules while through direction by DLG1, the APC
dimer is targeted to the leading edges of migrating cells [7].
APC is an important human tumor suppressor. Mutations in
APC are responsible for most of the cases of familial adenomatous
polyposis (FAP). DLG1 is the human homolog of the Drosophila lethal
(1) discs large-1 tumor suppressor. The APC/DLG1 protein complex
play important roles in the regulation of cell cycle progression [5],
cell migration and morphogenesis [6], and cell polarization [7]. In
addition, in some cases of FAP patients, mutations of the APC gene
Table 2. Data collection and refinement statistics.
PDZ1/APC-C11 PDZ2/APC-C11
Data collection
Space group P3 P21
Wavelength (A ˚) 0.97916 0.97916
Unit-cell parameters (A ˚) a=105.6,
b=105.6, c=50.8
a=67.8, b=87.4,
c=52.5, b=102.4u
Number of molecules/
asymmetric unit
65
Resolution range (A ˚) (outer
shell)
50.0-2.30 (2.38-2.30) 50.0-2.20 (2.28-
2.20)
Completeness (%)
(outer shell)
99.9 (100) 99.8 (99.9)
Redundancy (outer shell) 5.8 (4.9) 6.0 (6.0)
Total observations/Unique
reflections
164,145/28,225 184,827/30,730
Rmerge (%) (outer shell) 9.9 (35.3) 8.8 (21.6)
I/sI (outer shell) 16.3 (4.8) 16.8 (7.6)
Wilson B factor 32.9 28.3
Refinement
Rwork (%) 17.2 20.4
Rfree (%) 23.2 24.7
Overall B-factor 26.5 38.5
Average B factor for
APC-C11
57.7 55.8
Average B factor for
the PDZ domain
37.5 38.4
Rmsd bond lengths (A ˚) 0.009 0.012
Rmsd bond angles (u) 1.253 1.285
Ramachandran plot
(most favored, allowed,
disallowed, % )
94.4, 5.4, 0.2 96.5, 3.5, 0
Final model (Number of protein
atoms)
4,295 3,622
Final model (Number of water
molecules)
54 291
Rmerge=ShSi |Ih,i2Ih|/ShSi Ih,i for the intensity (I) of i observation of reflection h.
R factor=S||Fobs|2|Fcalc||/S|Fobs|, where Fobs and Fcalc are the observed and
calculated structure factors, respectively. Rfree=R factor calculated using 5% of
the reflection data chosen randomly and omitted from the start of refinement.
Rmsd, root-mean-square deviations from ideal geometry. Data for the highest
resolution shell are shown in parentheses.
doi:10.1371/journal.pone.0023507.t002
bands of WT or mutant PDZ2 domains. (C–D) Using the ITC assay to analyze the interactions between the mutant PDZ2 domains and APC-C11. (C)
The PDZ2 D339–346 mutant protein was titrated into the GST-APC-C11 protein, and no detectable interaction was observed. (D) The PDZ2 Q340P
mutant protein was titrated into the GST-APC-C11 protein, and the dissociation constant (Kd) of the PDZ2-Q340P/APC-C11 complex was measured to
be 9.80 mM.
doi:10.1371/journal.pone.0023507.g003
Figure 4. Overall structures of the PDZ1/APC-C11 complex and
the PDZ2/APC-C11 complex. (A) Overall structure of the PDZ1/APC-
C11 complex. PDZ1 is shown in green, while APC-C11 is shown in
yellow. Secondary structure elements of PDZ1 are labeled. (B) Overall
structure of the PDZ2/APC-C11 complex. PDZ2 is shown in cyan, while
APC-C11 is shown in yellow. Secondary structure elements of PDZ2 are
labeled.
doi:10.1371/journal.pone.0023507.g004
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2829) were found close to a site corresponding to the carboxy
terminus (codon 2843), the site of DLG1 binding [26–29].
Furthermore, several viral oncoproteins, including the high-risk
HPV E6 proteins [8,9], the adenovirus 9 E4 ORF1 protein [8], and
the HTLV-1 Tax protein [10], contain the PDZ-binding S/T-X-V
motifs in their C-terminus, and have been reported to bind to the
PDZ2 domain of DLG1. Therefore, it is possible that disruption of
the APC/DLG1 complex, either through mutations in APC or
DLG1 genes, or through competitive inhibition by the viral DLG1-
binding oncoproteins, might contribute to tumorigenesis.
Materials and Methods
Protein Expression and Purification
The cDNAs encoding PDZ1 (residues 220–310), PDZ2
(residues 315–410), PDZ3 (462–552), and PDZ1-PDZ2 (residues
220–410) domains of human DLG1 were cloned into pET28a
(Novagen)-derived vectors and over-expressed as N-terminal His-
tagged proteins. The C-terminal 11 residues of human APC
(residues 2833–2843, APC-C11, with sequence RHSGSYL-
VTSV), the C-terminal 4 residues of human APC (residues
2840–2843, APC-C4, sequence VTSV), and residues 2833–2842
of APC (APC-C10, sequence RHSGSYLVTS) were cloned into
the pGEX4T1 (GE Healthcare) vector to be expressed as N-
terminal GST-tagged recombinant proteins.
All proteins except PDZ1-PDZ2 were over-expressed in E. coli
strain BL21 (DE3), and PDZ1-PDZ2 was over-expressed in E. coli
strain BL21 (RIL). Cells were cultured at 37uC in LB medium and
incubated for 20 hours at 18uC with 0.5 mM isopropyl b-D-1-
thiogalactopyranoside (IPTG) on reaching OD600=0.6. Cells
were harvested by centrifugation and resuspended in the binding
buffer (Ni
2+-NTA column binding buffer: 25 mM Tris-HCl,
pH 8.0, 300 mM NaCl, and 20 mM imidazole; GST column
Figure 5. The interaction interface between the PDZ domains of DLG1 and the APC-C11 peptide. (A) Close-up stereo view of the
interface between PDZ1 and APC-C11 in the crystal structure of the PDZ1/APC-C11 complex. PDZ1 is shown in green, with its side chains shown in
purple. APC-C11 is shown in yellow. (B) Close-up stereo view of the interface between PDZ2 and APC-C11 in the crystal structure of the PDZ2/APC-
C11 complex. PDZ2 is shown in cyan, with its side chains shown in purple. APC-C11 is shown in yellow. Hydrogen bonds are represented by magenta
dashed lines. Oxygen and nitrogen atoms are shown as red and blue balls, respectively. (C) Sequence alignment of the last 20 residues of APC.
Protein sequences of human APC (2834–2843), Xenopus APC (2820–2829), zebrafish APC (2745–2754), sea urchin APC (3203–3212), and C. elegans
APR-1 (1179–1188) were aligned by the ClustalW method. Residues identical among all five homologues are highlighted in yellow, while residues
conserved in three out of five homologues are highlighted in orange. Accession numbers for each protein are indicated, and residue numbers for
human APC are marked above the sequences.
doi:10.1371/journal.pone.0023507.g005
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2 mM DTT). The cells were lysed by sonication, followed by
centrifugation. Supernatants of the cells lysates were purified by
Ni
2+-NTA affinity chromatography (Qiagen) or GST affinity
chromatography (GE Healthcare). PDZ1, PDZ2, PDZ3, and
PDZ1-PDZ2 proteins were then purified by Superdex 200 gel
filtration chromatography equilibrated with a buffer containing
20 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 2 mM DTT.
The peptide of the C-terminal 11 residues of APC was
chemically synthesized, and purified by reverse phase HPLC
(Tash Company). The PDZ1/APC-C11 protein complex and the
PDZ2/APC-C11 protein complex were prepared by mixing
concentrated proteins of PDZ1 or PDZ2 with the APC-C11
peptide, with a molar ratio of 1:1.5. The final concentration of the
PDZ1/APC-C11 complex was 28.4 mg/ml, and the final
concentration of the PDZ2/APC-C11 complex was 10.5 mg/ml.
The proteins were then flash-frozen in liquid nitrogen and stored
in 280uC until use.
Crystallization and structure determination
Crystals of the PDZ1/APC-C11 complex and the PDZ2/APC-
C11 complex were grown at 14uC by the hanging-drop, vapor-
diffusion method. Crystals of the PDZ1/APC-C11 complex were
grown in 0.1 M HEPES-Na pH 7.5, 0.8 M Na2HPO4, and 0.9 M
KH2PO4; while crystals of the PDZ2/APC-C11 complex were
grown in 0.05 M (NH4)2SO4, 0.1 M Bis-Tris pH 5.5, and 22%
PEG3,350. The data sets were collected at the beamline BL17U1
at Shanghai Synchrotron Radiation Facility (China).
Crystals of the PDZ1/APC-C11 complex belonged to the P3
space group, with six PDZ1/APC-C11 complexes in each
asymmetry unit. The structure was determined at 2.30 A ˚, by the
method of molecular replacement with the CCP4i program
PHASER [30] using the structure of DLG1-PDZ1 by itself (PDB
code: 1ZOK) as the search model. The residues of APC-C11 were
built into the electron density map with COOT [31]. After
refinement with the REFMAC program of CCP4i [30], the model
has an R factor of 17.2% and Rfree of 23.2%. The model quality
was checked with the PROCHECK program [30]. The final
model includes chain A: residues 220–309 of DLG1, chain B:
residues 220–246 and 250–310 of DLG1, chain C: residues 221–
310 of DLG1, chain D: residues 220–310 of DLG1, chain E:
residues 220–241 and 251–310 of DLG1, chain F: residues 220–
309 of DLG1, chain G: residues 2837–2843 of APC, chain H:
residues 2838–2842 of APC, chain I: residues 2838–2842 of APC,
chain J: residues 2838–2843 of APC, chain K: residues 2839–2843
of APC, and chain L: residues 2839–2842 of APC. In the
Ramachandran plot, 94.4%, 5.4%, and 0.2% of residues are in the
most favored, allowed, and disallowed regions, respectively.
Crystals of the PDZ2/APC-C11 complex belonged to the P21
space group, with four PDZ2 monomers and one PDZ2/APC-
C11 heterodimer in each asymmetry unit. The structure was
determined at 2.20 A ˚ resolution using the same method as the
structure of the PDZ1/APC-C11 complex. Despite considerable
effort, only one APC-C11 molecule could be located in complex
with PDZ2 in an asymmetry unit, and there was no observable
density for APC-C11 near the other four PDZ2 molecules.
Presumably the crystallization condition we used was not favorable
for the PDZ2/APC-C11 interaction, and therefore the occupancy
of APC-C11 was low in the crystals. After refinement, the model
has an R factor of 20.4% and Rfree of 24.7%. The final model
includes chain A: residues 316–409 of DLG1, chain B: residues
316–405 of DLG1, chain C: residues 316–410 of DLG1, chain D:
residues 316–409 of DLG1, chain E: residues 316–405 of DLG1,
and chain F: residues 2838–2843 of APC. In the Ramachandran
plot, 96.5%, 3.5%, and 0% of residues are in the most favored,
allowed, and disallowed regions, respectively.
GST pull-down assays
GST pull-down assays between wild-type (WT) or mutant APC
peptides and WT or mutant PDZ domain proteins were
performed according to standard procedures. The corresponding
fragments of DLG1 were added to GST-APC-C11/APC-C4/
APC-C10 protein pre-immobilized on the GST affinity column at
4uC, and then washed using the GST column binding buffer
(25 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 2 mM DTT).
The bound proteins were eluted with the GST column elution
buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 7 mM
glutathione), and then analyzed by SDS-PAGE and Coomassie
Blue staining.
Isothermal titration calorimetry assays
Isothermal titration calorimetry (ITC) experiments were
performed using an ITC200 system (GE Healthcare) at 25uC.
The buffer contained 50 mM HEPES, pH 7.5, and 100 mM
NaCl. Proteins were centrifuged and degassed before the
experiment. Typically, a WT or mutant DLG1 PDZ domain
protein (400 mM) was injected 20 times in 2 ml aliquots into a
300 ml sample cell containing GST-tagged APC-C11 or APC-C4
protein (40 mM). Data were fit with a nonlinear least-square
routine using a single site binding model with Origin for ITC
version 7.0 (MicroCal), varying the stoichiometry (n), the enthalpy
of the reaction (DH), and the association constant (Ka).
Figure 6. Conformational changes in PDZ1 and PDZ2 upon
binding to the APC-C11 peptide. (A) The conformational change in
PDZ1 upon binding to APC-C11. Structures of free PDZ1 (colored in
wheat) and APC-C11-bound PDZ1 (colored in green) were superim-
posed. (B) The conformational change in PDZ2 upon binding to APC-
C11. Structures of free PDZ2 (colored in wheat) and APC-C11-bound
PDZ2 (colored in cyan) were superimposed. The b1/b2 loops and the
b2/b3 loops of PDZ1 and PDZ2 are indicated.
doi:10.1371/journal.pone.0023507.g006
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All protein structure figures were generated with PyMOL
(http://pymol.sourceforge.net).
Accession codes
The atomic coordinates and structure factors of the PDZ1/
APC-C11 complex and those of the PDZ2/APC-C11 complex
have been deposited in the Protein Data Bank with accession
numbers 3RL7 and 3RL8, respectively.
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